2023
DOI: 10.2967/jnumed.123.265621
|View full text |Cite
|
Sign up to set email alerts
|

Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for89Zr-Trastuzumab

Abstract: The purpose of this study was to quantify any differences between the SUVs of 89 Zr immuno-PET scans obtained using a PET/CT system with a long axial field of view (LAFOV; Biograph Vision Quadra) compared to a PET/CT system with a short axial field of view (SAFOV; Biograph Vision) and to evaluate how LAFOV PET scan duration affects image noise and SUV metrics. Methods: Five metastatic breast cancer patients were scanned consecutively on SAFOV and LAFOV PET/CT scanners. Four additional patients were scanned usi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 39 publications
0
1
0
Order By: Relevance
“…In this immunoPET study, HER2-positive breast cancer patients were injected with 37 MBq [ 89 Zr]trastuzumab and scanned 4 days post injection on both SAFOV (Biograph mCT) and LAFOV (Biograph Vision Quadra) PET systems (Figure 1). Mohr and colleagues demonstrated that in an immunoPET study, the semiquantitative metrics (standardized uptake values (SUVs) and coefficient of variance) of a 30 min acquisition on a standard system was comparable with a 3 min acquisition on LAFOV, which means that a reduction of a factor of 10 would provide similar quality images (Figure 2) [22].…”
Section: Scan Time Reductionmentioning
confidence: 98%
See 2 more Smart Citations
“…In this immunoPET study, HER2-positive breast cancer patients were injected with 37 MBq [ 89 Zr]trastuzumab and scanned 4 days post injection on both SAFOV (Biograph mCT) and LAFOV (Biograph Vision Quadra) PET systems (Figure 1). Mohr and colleagues demonstrated that in an immunoPET study, the semiquantitative metrics (standardized uptake values (SUVs) and coefficient of variance) of a 30 min acquisition on a standard system was comparable with a 3 min acquisition on LAFOV, which means that a reduction of a factor of 10 would provide similar quality images (Figure 2) [22].…”
Section: Scan Time Reductionmentioning
confidence: 98%
“…Breath-hold (BH) studies on SAFOV PET/CT have already shown promising results in mitigating such effects [23,24]. Nevertheless, the high sensitivity of LAFOV PET/CT makes breath-hold Mohr and colleagues demonstrated that in an immunoPET study, the semiquantitative metrics (standardized uptake values (SUVs) and coefficient of variance) of a 30 min acquisition on a standard system was comparable with a 3 min acquisition on LAFOV, which means that a reduction of a factor of 10 would provide similar quality images (Figure 2) [22].…”
Section: Scan Time Reductionmentioning
confidence: 99%
See 1 more Smart Citation
“…49 For 89 Zr-PET imaging, the use of this "total body PET-scanner" holds many advantages. We anticipate a lower noise-induced bias in the SUV peak measurements 50 , together with enhanced lesion detection sensitivity, shorter imaging time and/or reduction in radiation dose, which can be quite extensive for 89 Zr-labeled antibodies. The precision in imaging lung lesions, as in our trial, could be improved by applying ultrafast acquisition motion correction techniques 51 .…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…The extended axial field-of-view (aFOV) of these scanners, ranging between 64 to 200 cm, increases solid angle coverage for the detection of coincident events, providing a higher sensitivity and relevant improvements in the signal-to-noise ratio (SNR) compared to conventional PET scanners with a short axial field-of-view (SAFOV) [6,7]. Notably, the improved sensitivity is advantageous for examinations with low event statistics, such as PET imaging with radioisotopes that have low branching ratios such as Y-90 [8,9], allowing for post-therapeutic PET scans after trans-arterial radioembolization with Y-90 microspheres; immuno-PET imaging with long half-life radioisotopes such as Zr-89 [10,11], which allows the improved in vivo characterization of various tumors such as HER2-positive breast cancer [12]; and examinations with reduced doses of injected activity, contributing to a reduction in radiation exposure [13,14].…”
Section: Introductionmentioning
confidence: 99%